Page last updated: 2024-11-04

rofecoxib and Dermatitis Medicamentosa

rofecoxib has been researched along with Dermatitis Medicamentosa in 12 studies

Research Excerpts

ExcerptRelevanceReference
" A few weeks later, during treatment with rofecoxib, a relapse appeared, including purpura."7.73[Rofecoxib-related cutaneous vasculitis]. ( Algayres, JP; Coutant, G; Defuentes, G; Lecoules, S, 2005)
" A few weeks later, during treatment with rofecoxib, a relapse appeared, including purpura."3.73[Rofecoxib-related cutaneous vasculitis]. ( Algayres, JP; Coutant, G; Defuentes, G; Lecoules, S, 2005)
"A 73-year-old woman was prescribed rofecoxib 25 mg/day for rheumatoid arthritis in addition to other medications on which the patient had been stabilized."3.72Lichenoid drug eruption probably associated with rofecoxib. ( Abu-Shraie, NA; Alfadley, AA, 2004)
"Rofecoxib, used for dysmenorrhea, caused a herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand."3.71Fixed drug eruption to rofecoxib. ( Florentino, FT; Gilliam, AC; Nedorost, ST, 2002)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nedorost, ST1
Florentino, FT1
Gilliam, AC1
Smith, KJ1
Skelton, H1
Lillicrap, MS1
Merry, P1
Zembowicz, A1
Mastalerz, L1
Setkowicz, M1
Radziszewski, W1
Szczeklik, A1
Rodríguez, M1
Enrique, E1
Castello, JV1
de Mateo, JA1
Roca, B1
Malek, T1
Abu-Shraie, NA1
Alfadley, AA1
Markus, R1
Reddick, ME1
Rubenstein, MC1
Drago, F1
Brusati, C1
Desirello, G1
Cacciapuoti, M1
Rebora, A1
Defuentes, G1
Lecoules, S1
Coutant, G1
Algayres, JP1
Schmutz, JL1
Barbaud, A1
Trechot, P1
Zollner, TM1
Ahlbach, S1
Kaufmann, R1
Boehncke, WH1
Kaur, C1
Sarkar, R1
Kanwar, AJ1

Trials

2 trials available for rofecoxib and Dermatitis Medicamentosa

ArticleYear
Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
    Archives of dermatology, 2003, Volume: 139, Issue:12

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Celecoxib; Comput

2003
[Tolerability of a selective cyclooxygenase-2-inhibitor (rofecoxib) in patients with intolerance reactions to nonsteroidal anti-inflammatory agents].
    Deutsche medizinische Wochenschrift (1946), 2001, Apr-06, Volume: 126, Issue:14

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Er

2001

Other Studies

10 other studies available for rofecoxib and Dermatitis Medicamentosa

ArticleYear
Fixed drug eruption to rofecoxib.
    Cutis, 2002, Volume: 70, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Dysmenorrhea; Erythema; Female; Huma

2002
Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitor.
    International journal of dermatology, 2003, Volume: 42, Issue:5

    Topics: Adult; Arthritis; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Lactones; Leg Dermatose

2003
Cutaneous vasculitis associated with rofecoxib.
    Rheumatology (Oxford, England), 2003, Volume: 42, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Lactones; Leg Dermatoses; M

2003
Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2003, Volume: 91, Issue:6

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib;

2003
Lichenoid drug eruption probably associated with rofecoxib.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5

    Topics: Aged; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Lactones; Su

2004
Rofecoxib-induced pseudoporphyria.
    Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Eruptions; Female; G

2004
Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:6

    Topics: Aged; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Lactones; Male; Middle A

2004
[Rofecoxib-related cutaneous vasculitis].
    Presse medicale (Paris, France : 1983), 2005, Aug-27, Volume: 34, Issue:14

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Drug Eruptions;

2005
[Pseudoporphyria and coxib].
    Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Celecoxib; Cyclooxygenase Inhibitors; Diagnosis, Di

2006
Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides.
    Dermatology (Basel, Switzerland), 2001, Volume: 203, Issue:4

    Topics: Adult; Cross Reactions; Cyclooxygenase Inhibitors; Drug Eruptions; Humans; Lactones; Male; Sulfonami

2001